article thumbnail

FDA backs pharmacist prescribing of Paxlovid for COVID

pharmaphorum

Some patients with COVID-19 will be able to get easier access to Pfizer’s oral antiviral therapy Paxlovid, after the FDA ruled that pharmacists would be able to prescribe the drug. Now, in addition to doctors and providers, the FDA announced pharmacists with your medical information can prescribe Paxlovid to patients. It made $1.5

FDA 93
article thumbnail

Since when did we believe that people would do what’s medically right?

World of DTC Marketing

COVID vaccines, already in use, have not received full FDA approval. The COVID-19 vaccine received emergency use authorization from the FDA months ago and has yet to receive full approval, which could lead to more people getting vaccinated. SUMMARY: The CDC is recommending that vaccinated people wear masks again in some states.

Medical 297
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

MedWand Solutions Receives FDA 510k Clearance

Legacy MEDSearch

Food and Drug Administration (FDA) has granted 510(k) clearance to the MedWand,” shared MedWand CEO and Co-Founder, Robert Rose. “As MedWand Mobile Clinic – Designed for physician or home visits and remote patient monitoring applications. To request a demo today visit www.medwand.com. “I I am happy to share that the U.S.

FDA 52
article thumbnail

Cerner Enviza and FDA partner to develop AI drug safety tools

Pharmaceutical Technology

Oracle company Cerner Enviza and John Snow Labs have collaborated with the US Food and Drug Administration (FDA) for the development of artificial intelligence (AI) tools for drug safety and real-world evidence studies. Together, Cerner Enviza and John Snow Labs have all the right expertise, data and technology to make it happen.”

Safety 59
article thumbnail

CMS’ Behavioral Health Strategy: Expanded Incident-to Billing and new BHI code in the proposed 2023 Medicare Physician Fee Schedule

Nixon Gwilt Law

to allow behavioral health services to be furnished by clinical staff under the general supervision of a physician or non-physician practitioner (“NPP”), so long as CMS’ “incident to” requirements and state licensure requirements are met.

article thumbnail

Selling to Physicians from a Physician’s Perspective

MedCepts

Therefore, the first thing to consider when selling to physicians is that your product, device or service is safe. In addition, it needs to be approved either by the FDA or other respective authorizing body. Physicians Seek Evidence based information. When selling to physicians, yours answers should preferably be evidence based.

article thumbnail

Considerations for Mobile Health Technology Developers: Part 1

pharmaphorum

Food and Drug Administration (FDA) regulation as a medical device. Determining whether a product is a medical device subject to FDA regulation necessarily begins with understanding the FDA regulatory definition of ‘medical device’. When assessing mHealth technology, the FDA will determine whether an application is either: i.